Peyman Hosseinchi

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 7

Top Venues

Nature biomedical engineering

Science translational medicine

Science advances

Molecular cancer therapeutics

University of Chicago (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Chicago

United States

PHD :: Pritzker School of Molecular Engineering

Publications

Aslan Mansurov, Peyman Hosseinchi, Kevin Chang, Abigail L Lauterbach, Laura T Gray, Aaron T Alpar, Erica Budina, Anna J Slezak, Seounghun Kang, Shijie Cao, Ani Solanki, Suzana Gomes, John-Michael Williford, Melody A Swartz, Juan L Mendoza, Jun Ishihara, Jeffrey A Hubbell
Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker. Nature biomedical engineering 6 (7) (2022)
Jun Ishihara, Ako Ishihara, Koichi Sasaki, Steve Seung-Young Lee, John-Michael Williford, Mariko Yasui, Hiroyuki Abe, Lambert Potin, Peyman Hosseinchi, Kazuto Fukunaga, Michal M Rączy, Laura T Gray, Aslan Mansurov, Kiyomitsu Katsumata, Masashi Fukayama, Stephen J Kron, Melody A Swartz, Jeffrey A Hubbell
Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Science translational medicine 11 (487) (2020)
Aslan Mansurov, Jun Ishihara, Peyman Hosseinchi, Lambert Potin, Tiffany M Marchell, Ako Ishihara, John-Michael Williford, Aaron T Alpar, Michal M Raczy, Laura T Gray, Melody A Swartz, Jeffrey A Hubbell
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nature biomedical engineering 4 (5) (2020)
Ako Ishihara, Jun Ishihara, Elyse A Watkins, Andrew C Tremain, Mindy Nguyen, Ani Solanki, Kiyomitsu Katsumata, Aslan Mansurov, Erica Budina, Aaron T Alpar, Peyman Hosseinchi, Lea Maillat, Joseph W Reda, Takahiro Kageyama, Melody A Swartz, Eiji Yuba, Jeffrey A Hubbell
Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature biomedical engineering 5 (5) (2020)
John-Michael Williford, Jun Ishihara, Ako Ishihara, Aslan Mansurov, Peyman Hosseinchi, Tiffany M Marchell, Lambert Potin, Melody A Swartz, Jeffrey A Hubbell
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Science advances 5 (12) (2019)
Jun Ishihara, Lambert Potin, Peyman Hosseinchi, Kazuto Fukunaga, Martina Damo, Thomas F Gajewski, Melody A Swartz, Jeffrey A Hubbell
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity. Molecular cancer therapeutics 17 (11) (2018)
Jun Ishihara, Kazuto Fukunaga, Ako Ishihara, Hans M Larsson, Lambert Potin, Peyman Hosseinchi, Gabriele Galliverti, Melody A Swartz, Jeffrey A Hubbell
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events. Science translational medicine 9 (415) (2018)

Peyman Hosseinchi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Peyman Hosseinchi